Prevalence of KIT expression in human tumors: Gallbladder cancer [6]

Journal of Clinical Oncology

Volumn 23, Issue 22, 2005, Pages 5268-5271

  Arroyo, Gerardo F ^a   Acosta, Gabriela ^b   Alvi, Marcelo Monteros ^a   Raspi, Ema ^c   Almonacid, Gerardo Vides ^c   Fabián, Haydeé ^d   Freire, María Fernández ^d  

^a Hospital Privado Santa Clara de Asís   (Argentina)

^b San Isidro Patología   (Argentina)

^c Laboratorio Privado de Patología   (Argentina)

^d Ciudad Autonoma de Buenos Aires   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; PROTEIN TYROSINE KINASE; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ADENOCARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL GROWTH; DOSE RESPONSE; DRUG INHIBITION; GALLBLADDER CANCER; HUMAN; HYPEREOSINOPHILIC SYNDROME; IMMUNOHISTOCHEMISTRY; LETTER; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ARGENTINA; BIOSYNTHESIS; GALLBLADDER TUMOR; GENE EXPRESSION PROFILING; GENETICS; NOTE; PATHOLOGY;

ARGENTINA; GALLBLADDER NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 24644494769     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.01.3409     Document Type: Letter

References (11)

1. Went PT, Dirnhofer S, Bundi M, et al: Prevalence of KIT expression in human tumors. J Clin Oncol 22:4514-4522, 2004
2. Matos EL, Loria DI, Zengarini N, et al: Atlas de mortalidad por cáncer en Argentina 1997-2001 [in Spanish]. Buenos Aires, Argentina, Bunge y Born Foundation, 2003
3. Landis SH, Murray T, Bolden S, et al: Cancer statistics 1999. CA Cancer J Clin 49:8-31, 1999
4. Crosby HA, Kelly DA, Strain AJ: Human hepatic stem-like cells isolated using KIT or CD34 can differentiate into biliary epithelium. Gastroenterology 120:534-544, 2001
5. Baumann U, Crosby HA, Ramani P, et al: Expression of the stem cell factor receptor KIT in normal and diseased pediatric liver: Identification of a human hepatic progenitor cell? Hepatology 30:112-117, 1999
6. Fujio K, Hu Z, Evarts RP, et al: Coexpression of stem cell factor and KIT in embryonic and adult liver. Exp Cell Res 224:243-250, 1996
7. Arroyo GF, Acosta G, Monteras Alvi M, et al: KIT expression in gallbladder cancer. Proc Am Soc Clin Oncol 22:303, 2003 (abstr 1215)
8. Aswad B, Constantinou M, Iannitti D, et al: KIT is a potential therapeutic target for biliary carcinomas. Proc Am Soc Clin Oncol 21:103b, 2002 (abstr 2227)
9. Merchant MS, Woo CW, Mackall CL, et al: Potential use of imatinib in Ewing's sarcoma: Evidence of in vitro and in vivo activity. J Natl Cancer Inst 94:1673-1679, 2002
10. Gleich GJ, Leiferman KM, Pardanani A, et al: Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet 359:1577-1578, 2002
11. Druker BJ, Sawyers CL, Kantarjian H, et al: Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1031-1037, 2001